All Relations between Schizophrenia and cannabis

Publication Sentence Publish Date Extraction Date Species
Thomas Schnell, Theresa Becker, Maria Chantal Thiel, Euphrosyne Gouzoulis-Mayfran. Craving in patients with schizophrenia and cannabis use disorders. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 58. issue 11. 2014-03-10. PMID:24246436. our investigation aimed to gain insight into the intensity and dimensions of cravings in patients with schizophrenia and cannabis use disorders (cuds), compared with otherwise healthy people with cuds (control subjects). 2014-03-10 2023-08-12 human
Shira Sagie, Yehuda Eliasi, Ido Livneh, Yosi Bart, Einat Monovic. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness]. Harefuah. vol 152. issue 12. 2014-02-20. PMID:24483000. apart from cognitive damage, current studies investigate how marijuana affects mental illness: a high correlation between cannabis use and schizophrenia was found and a high risk to undergo a psychotic attack. 2014-02-20 2023-08-12 Not clear
Shira Sagie, Yehuda Eliasi, Ido Livneh, Yosi Bart, Einat Monovic. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness]. Harefuah. vol 152. issue 12. 2014-02-20. PMID:24483000. furthermore, patients with schizophrenia who used cannabis showed a selective neuro-psychological disruption, and similar cognitive deficiencies and brain morphological changes were found among healthy cannabis users and schizophrenia patients. 2014-02-20 2023-08-12 Not clear
P Falkai, D Reich-Erkelenz, B Malchow, A Schmitt, K Majteny. [Brain development before onset of the first psychotic episode and during outcome of schizophrenia]. Fortschritte der Neurologie-Psychiatrie. vol 81. issue 5. 2014-01-08. PMID:23695790. this could explain how relevant environmental factors (pregnancy and birth complications, early childhood abuse or cannabis abuse) via risk genes might lead to a destabilized neuronal network which in the end could trigger schizophrenia symptoms on the behavioral level. 2014-01-08 2023-08-12 Not clear
David W Volk, Benjamin I Siegel, Christopher D Verrico, David A Lewi. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia research. vol 147. issue 1. 2013-12-09. PMID:23561296. adolescent cannabis use is associated with greater relative risk, increased symptom severity, and earlier age of onset of schizophrenia. 2013-12-09 2023-08-12 human
David W Volk, Benjamin I Siegel, Christopher D Verrico, David A Lewi. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia research. vol 147. issue 1. 2013-12-09. PMID:23561296. higher abhd6 mrna levels may increase 2-ag metabolism which may influence susceptibility to cannabis in the earlier stages of schizophrenia. 2013-12-09 2023-08-12 human
Atsushi Saito, Michael D L Ballinger, Mikhail V Pletnikov, Dean F Wong, Atsushi Kamiy. Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiology of disease. vol 53. 2013-12-04. PMID:23220619. accumulating epidemiological evidences suggest that cannabis use during adolescence is a potential environmental risk for the development of psychosis, including schizophrenia. 2013-12-04 2023-08-12 human
Zoran Vukadinovic, Merrill S Herman, Ivana Rosenzwei. Cannabis, psychosis and the thalamus: a theoretical review. Neuroscience and biobehavioral reviews. vol 37. issue 4. 2013-10-28. PMID:23458778. the role of cannabis in the etiology of schizophrenia has been documented as possibly the strongest environmental risk factor. 2013-10-28 2023-08-12 Not clear
Laura M Borgelt, Kari L Franson, Abraham M Nussbaum, George S Wan. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. vol 33. issue 2. 2013-10-25. PMID:23386598. safety concerns regarding cannabis include the increased risk of developing schizophrenia with adolescent use, impairments in memory and cognition, accidental pediatric ingestions, and lack of safety packaging for medical cannabis formulations. 2013-10-25 2023-08-12 Not clear
Maren Klug, Maarten van den Buus. An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice. Frontiers in behavioral neuroscience. vol 7. 2013-10-24. PMID:24155701. the aim of the present study was to investigate whether a bdnf deficit would modulate effects of chronic cannabis intake, a well-described risk factor for schizophrenia development. 2013-10-24 2023-08-12 mouse
Leonora E Long, Rose Chesworth, Xu-Feng Huang, Iain S McGregor, Jonathon C Arnold, Tim Kar. Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. The international journal of neuropsychopharmacology. vol 16. issue 1. 2013-10-17. PMID:22226049. heavy cannabis abuse increases the risk of developing schizophrenia. 2013-10-17 2023-08-12 mouse
Rachel A Rabin, Konstantine K Zakzanis, Zafiris J Daskalakis, Tony P Georg. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry research. vol 206. issue 2-3. 2013-09-17. PMID:23246245. effects of cannabis use status on cognitive function, in males with schizophrenia. 2013-09-17 2023-08-12 Not clear
Rachel A Rabin, Konstantine K Zakzanis, Zafiris J Daskalakis, Tony P Georg. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry research. vol 206. issue 2-3. 2013-09-17. PMID:23246245. cognitive impairment and cannabis use are common among patients with schizophrenia. 2013-09-17 2023-08-12 Not clear
Rachel A Rabin, Konstantine K Zakzanis, Zafiris J Daskalakis, Tony P Georg. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry research. vol 206. issue 2-3. 2013-09-17. PMID:23246245. we sought to examine cognitive performance as a function of cannabis use patterns in schizophrenia. 2013-09-17 2023-08-12 Not clear
Rachel A Rabin, Konstantine K Zakzanis, Zafiris J Daskalakis, Tony P Georg. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry research. vol 206. issue 2-3. 2013-09-17. PMID:23246245. cannabis status has minimal effects on cognition in males with schizophrenia. 2013-09-17 2023-08-12 Not clear
Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendre. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia research and treatment. vol 2013. 2013-08-23. PMID:23970971. growing evidence suggests that cannabis abuse/dependence is paradoxically associated with better cognition in schizophrenia. 2013-08-23 2023-08-12 human
Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendre. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia research and treatment. vol 2013. 2013-08-23. PMID:23970971. accordingly, we performed a functional magnetic resonance imaging (fmri) study of visuospatial abilities in 14 schizophrenia patients with cannabis abuse (dd), 14 nonabusing schizophrenia patients (scz), and 21 healthy controls (hcs). 2013-08-23 2023-08-12 human
Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendre. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia research and treatment. vol 2013. 2013-08-23. PMID:23970971. this latter result tentatively suggests that the neurophysiologic processes underlying visuospatial abilities are partially preserved in dd, relative to scz patients, consistently with the findings showing that cannabis abuse in schizophrenia is associated with better cognitive functioning. 2013-08-23 2023-08-12 human
Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendre. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia research and treatment. vol 2013. 2013-08-23. PMID:23970971. further fmri studies are required to examine the neural correlates of other cognitive dysfunctions in schizophrenia patients with and without comorbid cannabis use disorder. 2013-08-23 2023-08-12 human
J Vilain, A-M Galliot, J Durand-Roger, M Leboyer, P-M Llorca, F Schürhoff, A Szök. [Environmental risk factors for schizophrenia: a review]. L'Encephale. vol 39. issue 1. 2013-08-22. PMID:23177330. various environmental factors such as urbanicity, migration, cannabis, childhood traumas, infectious agents, obstetrical complications and psychosocial factors have been associated with the risk of developing schizophrenia. 2013-08-22 2023-08-12 Not clear